Lifeward has launched its ReWalk 7 personal exoskeleton in the U.S.

ReWalk 7 includes new and enhanced features like cloud connectivity and customizable walking speeds. These help offer a more functional and personalized walking experience for patient with spinal cord injury (SCI).

Users can choose between two customizable walking speeds to transition between indoor and outdoor walking environments. A Crutch Control feature puts device control at the user’s fingertips so they can stand, walk, select speeds, and stop.

A new wrist control smartwatch and MyReWalk mobile help users select operation modes, set goals, and track usage. An improved battery and seamless activation of stairs and curbs help to walk longer and more often, as well.

A new therapist handheld device and click-to-stop control allows safer, more effective progression to optimal gait patterns.

Lifeward collaborated with over two dozen end users and physical therapists as part of the U.S. Food and Drug Administration (FDA) clearance process to gather feedback on the device’s impact in both rehab and real-world settings. ReWalk 7 achieved FDA clearance last month.

In 2024, CMS finalized a Medicare reimbursement pathway for personal exoskeleton use.

“The feedback we received from clinicians and ReWalkers was invaluable,” said Jill Butler, PT, DPT, NCS, Director of Clinical Development for Lifeward and the Primary Investigator for usability testing. “Therapists felt that the handheld device will make training sessions much easier and more efficient, and ReWalk users were excited about the enhanced level of confidence and control they felt using the new crutch control unit. This feedback helped us to optimize the ReWalk to maximize success in real-world environments.”

“The ReWalk 7 was developed over several years, integrating advanced technological innovations with feedback from clinicians and patients to build upon the ReWalk’s world-class reputation for industry leadership,” said Larry Jasinski, CEO of Lifeward. “The result is a device that is optimized for real-world use, with an unmatched user experience and freedom of movement. We are thrilled to be able to provide paralyzed individuals across the country with a new option for integrating walking to everyday life.”

Jasinski announced he would step down as the company’s CEO after 13 years, continuing to serve in his roles through Q2 2025.